Polyneuropathy Treatment Market is Projected to Grow at a 4.9% CAGR, Reaching US$ 3.31 Billion by 2034 | Fact.MR Report [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Rockville, MD , Jan. 07, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global Polyneuropathy Treatment Market is set to reach US$ 2.05 billion in 2024 and further expand at a CAGR of from 2024 to 2034. Polyneuropathy represents the simultaneous malfunction of several peripheral nerves throughout the body. The polyneuropathy treatment market is witnessing growth, driven by advancements in medical research, a growing focus on pain management, disease awareness, and an increasing emphasis on personalized medicine. There is a huge opportunity for developing innovative medications and therapies to address unmet market needs. To provide more durable and effective treatments, this includes focuses on neuroregeneration, gene therapy, stem cell therapy, and neuromodulation techniques. Researchers have made significant progress in the last 10 years in understanding the mechanisms underlying neuropathic pain. As a result, ongoing
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Lightning Round: Powell Industries has been a ‘big, big disappointment', says Jim Cramer [CNBC]CNBC
- Stock market today: Indexes close lower as new data clouds rate cut views [Yahoo! Finance]Yahoo! Finance
- Work at Fortune [Fortune]Fortune
- Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at UBS Group AG from $31.00 to $29.00. They now have a "neutral" rating on the stock.MarketBeat
- Why Pfizer (PFE) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 10/29/24 - Beat
PFE
Sec Filings
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- PFE's page on the SEC website